Bosom Buddies of Arizona News

The Latest News

Subcutaneous Herceptin OK’d for Breast Cancer

  • 18 March 2019
  • Author: Erma Shaw
  • Number of views: 1064
  • 0 Comments

Study found 86% of patients preferred it to IV formulation. The FDA approved a subcutaneous version of trastuzumab (Herceptin) for treating HER2-positive breast cancer on Thursday.

Two randomized trials confirmed the safety and efficacy of the new formulation, which combines the anti-HER2 targeted agent with hyaluronidase, an endoglycosidase, and will be branded Herceptin Hylecta. Read More

 

Share this with your friends on

Print

Leave a comment

Name:
Email:
Comment:
CAPTCHA image
Enter the code shown above in the box below
Add comment

 


 
To refresh the top news stories, click here.

Contact Us

Bosom Buddies, Inc. is a
501(c)3 non-profit organization.

Bosom Buddies of Arizona

8433 North Black Canyon #100
Phoenix, AZ 85021 (map)
Phone:  602.265.2776
Information line:  602.231.6648
info@bosombuddies-az.org

Newsletter


Sign up for our newsletter and stay atop all the goings on with our support groups and their efforts. You can unsubscribe anytime.

Get Social

Facebook Twitter
   
Paypal Amazon Smiles

 

Terms Of UsePrivacy Statement©2019 Bosom Buddies of AZ. Website by Sprocket